Cognitive Anxiolytics

Apr 12, 2018 by in PSYCHIATRY Comments Off on Cognitive Anxiolytics

Herbal medicine Dosage Major/active constituents Key evidence Potential adverse effects Potential clinical use Clinical advice Brahmi (Bacopa monnieri) Acute: 320 mg or 640 mg of Brahmi extract Chronic: 300 mg/d…

read more

The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry

Apr 12, 2018 by in PSYCHIATRY Comments Off on The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry

© Springer International Publishing Switzerland 2017David Camfield, Erica McIntyre and Jerome Sarris (eds.)Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders10.1007/978-3-319-42307-4_1 1. The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry David A. Camfield1, 2  ,…

read more

Adaptogens

Apr 12, 2018 by in PSYCHIATRY Comments Off on Adaptogens

Herbal medicine Dosage Major/active constituents Key evidence PotentialAEs Potentialclinical use Clinical advice Ashwagandha (Withania somnifera) Total dose of 500–1000 mg/day dried extract standardised to withanolides, or 4–6 g/day root powder…

read more

The Therapeutic Potential of Ayahuasca

Apr 12, 2018 by in PSYCHIATRY Comments Off on The Therapeutic Potential of Ayahuasca

Herbal medicine Dosage Major/Active Constituents Key evidence Potential AEs Potential clinical use Clinical advice Ayahuasca ( Psychotria viridis plus Banisteriopsis caapi; or B. caapi plus Diplopterys cabrerana) Variable dosage MAOI:…

read more

Treatments for Comorbid Anxiety and Mood Disorders

Apr 12, 2018 by in PSYCHIATRY Comments Off on Treatments for Comorbid Anxiety and Mood Disorders

Nutraceutical Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice St John’s wort (Hypericum perforatum) 1 mg of hypericin per day (one or two times per day);…

read more

Pharmacotherapy of Pathological Grief Responses

Apr 12, 2018 by in PSYCHIATRY Comments Off on Pharmacotherapy of Pathological Grief Responses

Authors (year) Design Population Duration Time since loss Drug Results Bereavement-related depression Jacobs et al. [8] Open-label (ITT) n = 10, age range = 26–65, 80% women 4 weeks  Desipramine, 75–150 mg/day Depressive symptoms: 70% responders…

read more

Two Psychosocial Interventions for Complicated Grief: Review of Principles and Evidence Base

Apr 12, 2018 by in PSYCHIATRY Comments Off on Two Psychosocial Interventions for Complicated Grief: Review of Principles and Evidence Base

© Springer Science+Business Media LLC 2018Eric Bui (ed.)Clinical Handbook of Bereavement and Grief Reactions Current Clinical Psychiatryhttps://doi.org/10.1007/978-3-319-65241-2_12 12. Two Psychosocial Interventions for Complicated Grief: Review of Principles and Evidence Base Emily B. O’Day1 and Elizabeth M. Goetter1, 2  …

read more

Grief Reactions in the Elderly

Apr 12, 2018 by in PSYCHIATRY Comments Off on Grief Reactions in the Elderly

Figure 6.1 fMRI studies provide data correlating behavioral dimensions of complicated grief with activity in underlying neurobiological substrates Table Citations: [95, 96, 99, 100, 105–107]. Evaluation—Clinical Presentation and Diagnosis Clinical…

read more
Get Clinical Tree app for offline access